Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Vascular & Endovascular: Statins effective in older stroke patients | New data on stroke mortality among men & women

News You Need to Know Today
Vascular & Endovascular: Statins effective in older stroke patients | New data on stroke mortality among men & women
Wednesday, February 24, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Vascular & Endovascular

A look at the future? Engineers propose a new design for mechanical heart valves

The team behind the new-look valves hope their design will limit blood clots and boost patient care. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

A look at the future? Engineers propose a new design for mechanical heart valves

Share on Twitter Share on Facebook Share on Linkedin
The team behind the new-look valves hope their design will limit blood clots and boost patient care. 
READ MORE >

Shockwave’s IVL technology gains FDA approval for treating advanced coronary artery disease

Shockwave Medical announced Tuesday, Feb. 16, that intravascular lithotripsy (IVL) has gained FDA approval for the treatment of severely calcified coronary artery disease.

READ MORE >
The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.
Share on Twitter Share on Facebook Share on Linkedin

Shockwave’s IVL technology gains FDA approval for treating advanced coronary artery disease

Share on Twitter Share on Facebook Share on Linkedin
The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.
Shockwave Medical announced Tuesday, Feb. 16, that intravascular lithotripsy (IVL) has gained FDA approval for the treatment of severely calcified coronary artery disease.
READ MORE >

Statins still effective in older stroke patients, reducing the risk of cardiovascular events and death

The study's authors aimed to learn more about an area where clinical evidence was lacking: statin therapy for stroke patients 80 years old and older. 

READ MORE >
Treating elderly atrial fibrillation (AFib) patients—even those who are traditionally ineligible for direct oral anticoagulants (DOACs)—with a very low dose of edoxaban is associated with improved outcomes, according to new research published in JAMA Network Open.
Share on Twitter Share on Facebook Share on Linkedin

Statins still effective in older stroke patients, reducing the risk of cardiovascular events and death

Share on Twitter Share on Facebook Share on Linkedin
Treating elderly atrial fibrillation (AFib) patients—even those who are traditionally ineligible for direct oral anticoagulants (DOACs)—with a very low dose of edoxaban is associated with improved outcomes, according to new research published in JAMA Network Open.
The study's authors aimed to learn more about an area where clinical evidence was lacking: statin therapy for stroke patients 80 years old and older. 
READ MORE >

Direct oral anticoagulants safer than warfarin for AFib patients with bioprosthetic heart valves

The analysis, published in the American Journal of Cardiology, focused on both the safety and effectiveness of these two treatment options. 

READ MORE >
Doctor mask covid
Share on Twitter Share on Facebook Share on Linkedin

Direct oral anticoagulants safer than warfarin for AFib patients with bioprosthetic heart valves

Share on Twitter Share on Facebook Share on Linkedin
Doctor mask covid
The analysis, published in the American Journal of Cardiology, focused on both the safety and effectiveness of these two treatment options. 
READ MORE >

Drinking green tea or coffee can reduce all-cause mortality for stroke, heart attack survivors

Drinking coffee also benefits patients who have not experienced a stroke or heart attack, though the impact is not as significant. 

READ MORE >
tea coffee drink quiet read
Share on Twitter Share on Facebook Share on Linkedin

Drinking green tea or coffee can reduce all-cause mortality for stroke, heart attack survivors

Share on Twitter Share on Facebook Share on Linkedin
tea coffee drink quiet read
Drinking coffee also benefits patients who have not experienced a stroke or heart attack, though the impact is not as significant. 
READ MORE >

What new research tells us about stroke mortality among men and women

Prior to popular belief, sex may not necessarily be an independent risk factor for stroke mortality, according to the analysis. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

What new research tells us about stroke mortality among men and women

Share on Twitter Share on Facebook Share on Linkedin
Prior to popular belief, sex may not necessarily be an independent risk factor for stroke mortality, according to the analysis. 
READ MORE >

USPSTF recommends against screening healthy adults for carotid artery stenosis

"Screening for CAS in adults without symptoms does more harm than good, and we continue to recommend against it," one USPSTF representative said. 

READ MORE >
Negative opinion
Share on Twitter Share on Facebook Share on Linkedin

USPSTF recommends against screening healthy adults for carotid artery stenosis

Share on Twitter Share on Facebook Share on Linkedin
Negative opinion
"Screening for CAS in adults without symptoms does more harm than good, and we continue to recommend against it," one USPSTF representative said. 
READ MORE >

American Heart Association explores close ties between mental, cardiovascular health

Depression, chronic stress, anxiety and anger are all associated with a heightened risk of heart rhythm irregularities, stroke and other serious cardiovascular conditions. 

READ MORE >
sad crying man
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association explores close ties between mental, cardiovascular health

Share on Twitter Share on Facebook Share on Linkedin
sad crying man
Depression, chronic stress, anxiety and anger are all associated with a heightened risk of heart rhythm irregularities, stroke and other serious cardiovascular conditions. 
READ MORE >

No reason to quit: TAVR patients can continue anticoagulation therapy throughout procedure

Patients are typically told to put anticoagulation therapy on hold two to four days before they undergo TAVR. This study’s authors aimed to see if this was truly necessary.  

READ MORE >
Driven by its strategic goal to advance equity in the U.S. healthcare innovation sector, the American Medical Association (AMA) recently announced an initiative that supports leading industry stakeholders in committing to equitable health innovation opportunities targeted to improving health outcomes in historically marginalized communities. #Healthdisparities 
Share on Twitter Share on Facebook Share on Linkedin

No reason to quit: TAVR patients can continue anticoagulation therapy throughout procedure

Share on Twitter Share on Facebook Share on Linkedin
Driven by its strategic goal to advance equity in the U.S. healthcare innovation sector, the American Medical Association (AMA) recently announced an initiative that supports leading industry stakeholders in committing to equitable health innovation opportunities targeted to improving health outcomes in historically marginalized communities. #Healthdisparities 
Patients are typically told to put anticoagulation therapy on hold two to four days before they undergo TAVR. This study’s authors aimed to see if this was truly necessary.  
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Cardiologist compensation keeps climbing | Investing in robotic tech | Doc agrees to pay $6.7M | Virtual nurses
ASNC speaks to policymakers | New IVL tech impresses | FDA clears high-pressure balloon catheter | RSNA names a new editor
Pacemakers recalled again | Johnson & Johnson makes a move | GLP-1 drugs & AFib | Strokes after PFA | New LAAO data
More recalls announced due to high-risk device | AATS helps surgeons manage a major complication | How guidelines impact care
Week in Review: TAVR or SAVR? | Key trends in cardiac CT | Fraud allegations lead to $6.7M settlement | CTO PCI
FDA clears intravascular imaging tech | Key trends in cardiac CT | Heartflow sues rival | Opportunistic screening
Vascular specialist agrees to pay $6.7M | Robotic heart surgery: Worth the cost? | E-cigarette concerns | Heart tech on display

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …4
    • Page 5
    • Page 6
    • Page 7
    • Current page 8
    • Page 9
    • Page 10
    • Page 11
    • Page 12 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme